Mike Thompson, MD, PhD, FASCO
@mtmdphd
Views my own. VP Clinical Partnerships @TempusAI #PrecisionMedicine #mmsm #lymsm #CCC19 @COVID19nCCC @ASCO COI: https://t.co/A6GQmWYvau
13-09-2010 18:03:36
143,4K Tweets
23,1K Followers
3,9K Following
Real World Third COVID19 Vaccine Dosing and Antibody Response in Patients with Hematologic Malignancies [Jul 18, 2022] Mike Thompson, MD, PhD, FASCO , Hallmeyer, Veronica Fitzpatrick , Liao, Michael Mullane, MD Stephen Medlin , Copeland, Jim Weese JPCRR institutionalrepository.aah.org/jpcrr/vol9/iss… #COVID19nCancer #COVID19Vaccine #IDonc
![Real World Third COVID19 Vaccine Dosing and Antibody Response in Patients with Hematologic Malignancies [Jul 18, 2022] @mtmdphd , Hallmeyer, @vrepublic , Liao, @mullane_michael @scmedlin , Copeland, @JimW9200 @JPCRR institutionalrepository.aah.org/jpcrr/vol9/iss… #COVID19nCancer #COVID19Vaccine #IDonc](https://pbs.twimg.com/media/GMSqRykXYAAcw0Z.png "Mike Thompson, MD, PhD, FASCO (@mtmdphd) on Twitter photo 2024-04-29 00:16:53 Real World Third COVID19 Vaccine Dosing and Antibody Response in Patients with Hematologic Malignancies [Jul 18, 2022] @mtmdphd , Hallmeyer, @vrepublic , Liao, @mullane_michael @scmedlin , Copeland, @JimW9200 @JPCRR institutionalrepository.aah.org/jpcrr/vol9/iss… #COVID19nCancer #COVID19Vaccine #IDonc")